Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Neuroprotective polypeptide reported by Amgen

Dec. 24, 1996

Algos and Interneuron codevelop novel antimigraine combination

Dec. 23, 1996

Northwest Neurologic and Wyeth-Ayerst neurodegenerative disorder collaboration

Dec. 23, 1996

Regeneron claims novel use for neurotrophic factor

Dec. 23, 1996

IND filed for chirally pure ADHD treatment

Dec. 20, 1996

Spray formulation of antimigraine Rx cleared for marketing

Dec. 20, 1996

Medtronic and Orphan Medical to develop intrathecal clonidine

Dec. 19, 1996

New insights into migraine pathology

Dec. 19, 1996

NK1 receptor antagonist synthesized by RPR

Dec. 19, 1996

DuPont Merck developing atypical antipsychotic

Dec. 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...